Veronese Nicola, Notarnicola Maria, Osella Alberto Ruben, Cisternino Anna Maria, Reddavide Rosa, Inguaggiato Rosa, Guerra Vito, Rotolo Ornella, Zinzi Iris, Chiloiro Marisa, Leandro Gioacchino, Correale Mario, Tutino Valeria, Misciagna Giovanni, Bonfiglio Caterina, Caruso Maria Gabriella
Ambulatory of Clinical Nutrition, National Institute of Gastroenterology-Research Hospital, IRCCS "S. de Bellis", Castellana Grotte, Bari, Italy.
Laboratory of Nutritional Biochemistry, National Institute of Gastroenterology-Research Hospital, IRCCS "S. de Bellis", Castellana Grotte, Bari, Italy.
Endocr Metab Immune Disord Drug Targets. 2018;18(5):513-521. doi: 10.2174/1871530318666180423101755.
Estrogens could protect the liver from fatty degeneration, but there is little information about whether menopause is associated with the severity of alcoholic (AFL) and non-alcoholic fatty liver (NAFL). Our aim was to evaluate the distribution of fatty liver detected by ultrasound in pre- and post-menopausal women and the factors associated with these conditions.
In this cross-sectional study, the years from menopause were investigated through selfreported information. The degree of fatty liver was assessed through a standardized ultrasound examination (scores 0 to 6, higher values reflecting a greater severity). Liver steatosis was classified as NAFL or AFL based on a daily alcohol intake > 20g/d.
The study included 752 women in menopause and 535 in pre-menopause. The years from menopause were not associated with the severity of liver steatosis in NAFL (p for trend=0.74; Spearman correlation=0.04; 95%CI: -0.09 to 0.17), whereas all the indexes of adiposity and the number of metabolic syndrome factors were associated with a higher liver steatosis score. Taking AFL liver steatosis as the outcome, the years since menopause were not significantly associated with liver steatosis in AFL (p for trend=0.50; Spearman correlation=0.09; 95%CI: -0.17 to 0.34), whilst the association between anthropometric parameters and liver steatosis severity resulted stronger in postmenopausal compared to pre- menopausal women.
the higher prevalence of fatty liver observed in post-menopausal women is probably not due to menopause per se, but to the adiposity (particularly abdominal) typical of this age and its consequences (such as metabolic syndrome).
雌激素可保护肝脏免受脂肪变性影响,但关于绝经是否与酒精性脂肪性肝病(AFL)和非酒精性脂肪性肝病(NAFL)的严重程度相关的信息较少。我们的目的是评估绝经前后女性超声检测出的脂肪肝分布情况以及与这些情况相关的因素。
在这项横断面研究中,通过自我报告信息调查绝经年限。通过标准化超声检查评估脂肪肝程度(评分0至6分,分数越高反映严重程度越高)。根据每日酒精摄入量>20g/d将肝脂肪变性分为NAFL或AFL。
该研究纳入了752名绝经后女性和535名绝经前女性。绝经年限与NAFL中肝脂肪变性的严重程度无关(趋势p=0.74;Spearman相关性=0.04;95%CI:-0.09至0.17),而所有肥胖指标和代谢综合征因素数量均与较高的肝脂肪变性评分相关。以AFL肝脂肪变性为结果,绝经后年限与AFL中的肝脂肪变性无显著相关性(趋势p=0.50;Spearman相关性=0.09;95%CI:-0.17至0.34),而与绝经前女性相比,绝经后女性人体测量参数与肝脂肪变性严重程度之间的关联更强。
绝经后女性中观察到的较高脂肪肝患病率可能并非源于绝经本身,而是源于该年龄段典型的肥胖(尤其是腹部肥胖)及其后果(如代谢综合征)。